Correlation Between Milestone Pharmaceuticals and MediciNova

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and MediciNova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and MediciNova into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and MediciNova, you can compare the effects of market volatilities on Milestone Pharmaceuticals and MediciNova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of MediciNova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and MediciNova.

Diversification Opportunities for Milestone Pharmaceuticals and MediciNova

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Milestone and MediciNova is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and MediciNova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MediciNova and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with MediciNova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MediciNova has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and MediciNova go up and down completely randomly.

Pair Corralation between Milestone Pharmaceuticals and MediciNova

Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to under-perform the MediciNova. In addition to that, Milestone Pharmaceuticals is 1.04 times more volatile than MediciNova. It trades about -0.02 of its total potential returns per unit of risk. MediciNova is currently generating about 0.02 per unit of volatility. If you would invest  212.00  in MediciNova on August 26, 2024 and sell it today you would earn a total of  1.00  from holding MediciNova or generate 0.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Milestone Pharmaceuticals  vs.  MediciNova

 Performance 
       Timeline  
Milestone Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Milestone Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Milestone Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
MediciNova 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.

Milestone Pharmaceuticals and MediciNova Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Milestone Pharmaceuticals and MediciNova

The main advantage of trading using opposite Milestone Pharmaceuticals and MediciNova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, MediciNova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will offset losses from the drop in MediciNova's long position.
The idea behind Milestone Pharmaceuticals and MediciNova pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements